| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000039780 |
| Receipt No. | R000045353 |
| Scientific Title | Analysis of brain activities and behavior for assessment of decision-making function prior to and following Deep Brain Stimulation for severe Tourette syndrome |
| Date of disclosure of the study information | 2020/03/12 |
| Last modified on | 2020/03/12 (Ver. 1) |
| Basic information | ||
| Public title | Analysis of brain activities and behavior prior to and following Deep Brain Stimulation for severe Tourette syndrome | |
| Acronym | Analysis of brain activities and behavior prior to and following Deep Brain Stimulation for severe Tourette syndrome | |
| Scientific Title | Analysis of brain activities and behavior for assessment of decision-making function prior to and following Deep Brain Stimulation for severe Tourette syndrome | |
| Scientific Title:Acronym | Analysis of brain activities and behavior for assessment of decision-making function prior to and following Deep Brain Stimulation for severe Tourette syndrome | |
| Region |
|
|
| Condition | |||
| Condition | Severe Tourette syndrome | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To clarify pathophysiology and brain function of Tourette syndrome. To assess how brain stimulation induces neuropsycological change using neuropsycholotigal testings and brain MRI. Also to identify factors associated with beneficial effects by deep brain stimulation. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Resting state functional MRI |
| Key secondary outcomes | Neuropsycological assessment data |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients meet the approved study (approved number 2017M098) criteria.
The operation criteria are following, 1.Patients with Dystonic tic who are to undergo DBS covered by national Health Care Insurance System 2.Patients over 12 years old. If patients under 12 years old are applicable to the surgery of severe involuntary movement, medical ethical committee will deliberate it. 3.Patients signed an informed consent document. 4.Patient's legal representatives sign an informed consent document if patients are minor. 5.Patients meet DSM-4 for clinical diagnose criteria of Tourette syndrome 6.Patients with severe involuntary movements over 35/50 points on YGTSS in principle. If a patient is life-threatening condition or has difficulty living by involuntary movements even though YGTSS score or treatment period don't meet the inclusion criteria, several clinical departments should discuss carefully and consider the patient's applicability to the surgery 7.More than minimum 6-month medication or psychological therapy failed to improve the symptoms or those were intolerant because of side effects. 8.Multiple departments including with psychiatry, neurosurgery, neurology and pediatrics departments (if the patient is a child) should discuss indication of surgery. |
|||
| Key exclusion criteria | 1.High risk patients with physical or mental complications (severe cardiovascular disorder, severe respiratory dysfunction, severe blood diseases, epilepsy, medical history of severe head injuries, severe stroke, severe neurodegenerative diseases, autism, schizophrenic, manic depression, drug addictions, pregnant, breast-feeding , female patients of child-bearing potential)
2.Patients ineligible to the study based on investigator's decision. |
|||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Fukuoka University Hospital | ||||||
| Division name | Department of Neurosurgery | ||||||
| Zip code | 814-0180 | ||||||
| Address | 7-45-1, Nanakuma, Johnan-ku, Fukuoka, 814-0180, Japan | ||||||
| TEL | 092-801-1011 | ||||||
| toinoue@fukuoka-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Fukuoka University Hospital | ||||||
| Division name | Department of Neurosurgery | ||||||
| Zip code | 814-0180 | ||||||
| Address | 7-45-1, Nanakuma, Johnan-ku, Fukuoka, 814-0180, Japan | ||||||
| TEL | 092-801-1011 | ||||||
| Homepage URL | |||||||
| tmorishita@fukuoka-u.ac.jp | |||||||
| Sponsor | |
| Institute | Fukuoka University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan society for the promotion of science |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Fukuoka University Medical Ethics Review Board |
| Address | 7-45-1, Nanakuma, Johnan-ku, Fukuoka, 814-0180, Japan |
| Tel | 092-801-1011 |
| fumed-ethics@fukuoka-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 福岡大学病院(福岡) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Identifying factors that predict beneficial treatment effects will enable patient selection for applicable treatment |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045353 |